CapEx at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is West Pharmaceutical Services's capex?
- West Pharmaceutical Services (WST) reported capex of $42.7M in Q1 2026.
- How has West Pharmaceutical Services's capex changed year-over-year?
- West Pharmaceutical Services's capex decreased by 40.1% year-over-year, from $71.3M to $42.7M.
- What is the long-term trend for West Pharmaceutical Services's capex?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's capex has grown at a 3.1% compound annual growth rate (CAGR), from $253.4M to $285.9M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.